| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Genitourinary Imaging |
1 From Diagnostikum Graz-Südwest and Medical School, Karl Franzens University, Weblinger Gürtel 25, 8054 Graz, Austria (D.H.S., K.W.P.); Departments of Radiology (P.R., H. Schoellnast), Internal Medicine (T.B., H. Samonigg), and Urology (H.T.) and Institute for Medical Informatics, Statistics and Documentation (A.B.), Karl Franzens University and University Hospital, Graz, Austria; and Department of Radiology, University of Michigan Medical Center, Ann Arbor, Mich (M.K.). Received November 21, 2003; revision requested February 6, 2004;revision received March 27; accepted May 17. Address correspondence to D.H.S. (e-mail: dieter.szolar@diagnostikum-graz.at).
PURPOSE: To retrospectively measure the adrenal gland attenuation and the percentage loss of adrenal gland enhancement at delayed contrast medium–enhanced computed tomography (CT) in patients with adrenocortical carcinomas and pheochromocytomas and to compare these data with those in patients with adenomas and metastases.
MATERIALS AND METHODS: The study protocol was approved by the ethics committee, which waived informed consent. Eleven patients with proved adrenocortical carcinoma, 17 with proved pheochromocytoma, 23 with adrenal adenoma, and 16 with metastasis to the adrenal gland underwent helical CT. Nonenhanced CT was followed by contrast-enhanced CT 1 minute and 10 minutes later. Attenuation and enhancement loss values were calculated.
RESULTS: The mean attenuation of adenomas (8 HU ± 18 [standard deviation]) was significantly lower than those of adrenocortical carcinomas (39 HU ± 14), pheochromocytomas (44 HU ± 11), and metastases (34 HU ± 11) on nonenhanced CT scans (P < .001). Although the mean attenuation values for nonadenomas (ie, adrenocortical carcinomas, pheochromocytomas, and metastases) were significantly higher than the value for adenomas on the 1-minute contrast-enhanced CT scans (P < .001), there was more overlap in attenuation between adenomas and nonadenomas on contrast-enhanced scans than on nonenhanced scans. On the 10-minute delayed contrast-enhanced scans, the mean attenuation of adenomas (32 HU ± 17) was significantly lower than the mean attenuations of carcinomas (72 HU ± 15), pheochromocytomas (83 HU ± 14), and metastases (66 HU ± 13) (P < .001). At optimal threshold values of 50% for absolute percentage of enhancement loss and 40% for relative percentage of enhancement loss at 10 minutes, both the sensitivity and the specificity for the diagnosis of adenoma were 100% when adenomas were compared with carcinomas, pheochromocytomas, and metastases.
CONCLUSION: The enhancement loss in adrenocortical carcinomas and pheochromocytomas is similar to that in adrenal metastases but significantly less than that in adrenal adenomas. The percentage change in contrast material washout is a useful adjunct to absolute CT attenuation values in differentiating adrenal adenomas from adrenocortical carcinomas and pheochromocytomas.
© RSNA, 2005
This article has been cited by other articles:
|
|
 |
|
  J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al. Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience Radiology, December 1, 2007; 245(3): 788 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ilias, A. Sahdev, R. H Reznek, A. B Grossman, and K. Pacak The optimal imaging of adrenal tumours: a comparison of different methods Endocr. Relat. Cancer, September 1, 2007; 14(3): 587 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Park, C. K. Kim, B. Kim, and J. H. Lee Comparison of Delayed Enhanced CT and Chemical Shift MR for Evaluating Hyperattenuating Incidental Adrenal Masses Radiology, June 1, 2007; 243(3): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bessell-Browne and M. E. O'Malley CT of Pheochromocytoma and Paraganglioma: Risk of Adverse Events with IV Administration of Nonionic Contrast Material Am. J. Roentgenol., April 1, 2007; 188(4): 970 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Young Jr. The Incidentally Discovered Adrenal Mass N. Engl. J. Med., February 8, 2007; 356(6): 601 - 610. [Full Text] [PDF]
|
|
|
|
 |
|
 I. C. Mitchell and F. E. Nwariaku Adrenal Masses in the Cancer Patient: Surveillance or Excision Oncologist, February 1, 2007; 12(2): 168 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Jhaveri, F. Wong, S. Ghai, and M. A. Haider Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. Am. J. Roentgenol., November 1, 2006; 187(5): 1303 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Yoon, E. M. Remer, and B. R. Herts Incidental pheochromocytoma mimicking adrenal adenoma because of rapid contrast enhancement loss. Am. J. Roentgenol., November 1, 2006; 187(5): 1309 - 1311. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Allolio and M. Fassnacht Adrenocortical Carcinoma: Clinical Update J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2027 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Happel, G. Heinz-Peer, D. H. Szolar, and M. T. Korobkin Enhancement Characteristics of Pheochromocytomas Radiology, January 1, 2006; 238(1): 373 - 374. [Full Text] [PDF]
|
|
|
|
|
|
M. K. Kalra, M. A. Blake, G. W. Boland, and P. F. Hahn CT Features of Adrenal Pheochromocytomas: Attenuation Value and Loss of Contrast Enhancement Radiology, September 1, 2005; 236(3): 1112 - 1113. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
